Stocks Comparison
QuidelOrtho vs Trinity Biotech: revenue, profit, margins and growth compared
QuidelOrtho brought in $2.7B of revenue in fiscal 2025, Trinity Biotech $61.6M in fiscal 2024. Revenue changed by -1.9% at QuidelOrtho and +8.3% at Trinity Biotech on the year before, so Trinity Biotech grew faster. QuidelOrtho kept -41.5% of its revenue as net profit, Trinity Biotech -51.6%. Free cash flow was -$83M at QuidelOrtho and -$4.6M at Trinity Biotech.
Side by side, latest fiscal year
| QDEL | TRIB | |
|---|---|---|
| Fiscal year ended | FY2025 (December 28, 2025) | FY2024 (December 31, 2024) |
| Revenue | $2.7B | $61.6M |
| Revenue growth | -1.9% | +8.3% |
| Net income | -$1.1B | -$31.8M |
| Net margin | -41.5% | -51.6% |
| Free cash flow | -$83M | -$4.6M |
| Free cash flow margin | -3.0% | -7.5% |
| Earnings per share (diluted) | -$16.69 | n/a |
| Cash | $169.8M | $5.2M |
| Debt | $2.7B | n/a |
| Price to earnings | n/a | n/a |
| Market value | $750.2M | $5.5M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #91 of 646 · Health care | #358 of 646 · Health care |
Over the years
Questions about QuidelOrtho and Trinity Biotech
Which is bigger by revenue, QuidelOrtho or Trinity Biotech?
QuidelOrtho is bigger by revenue: $2.7B in fiscal 2025, against $61.6M for Trinity Biotech in fiscal 2024.
Which keeps more of its revenue as profit, QuidelOrtho or Trinity Biotech?
QuidelOrtho had a net margin of -41.5% in fiscal 2025; Trinity Biotech had -51.6% in fiscal 2024.
Which grew revenue faster, QuidelOrtho or Trinity Biotech?
In their latest fiscal years revenue changed by -1.9% at QuidelOrtho and +8.3% at Trinity Biotech.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.